National Health Investors, Inc. Stock

Equities

NHI

US63633D1046

Specialized REITs

Market Closed - Nyse 16:00:02 2024-06-12 EDT 5-day change 1st Jan Change
65.35 USD +1.11% Intraday chart for National Health Investors, Inc. -1.82% +17.01%
Sales 2024 * 320M 440M Sales 2025 * 343M 471M Capitalization 2.84B 3.9B
Net income 2024 * 124M 170M Net income 2025 * 133M 183M EV / Sales 2024 * 12.7 x
Net Debt 2024 * 1.24B 1.7B Net Debt 2025 * 1.32B 1.82B EV / Sales 2025 * 12.1 x
P/E ratio 2024 *
22.9 x
P/E ratio 2025 *
22 x
Employees 27
Yield 2024 *
5.53%
Yield 2025 *
5.61%
Free-Float 95.38%
More Fundamentals * Assessed data
Dynamic Chart
Declaration of Voting Results by National Health Investors CI
Land & Buildings Investment Management Comments on National Health Investors? Supplemental Proxy Statement CI
Transcript : National Health Investors, Inc., Q1 2024 Earnings Call, May 07, 2024
National Health Investors' Q1 Normalized FFO Rises, Revenue Drops; 2024 Outlook Raised; Dividend Maintained MT
Earnings Flash (NHI) NATIONAL HEALTH INVESTORS Reports Q1 Revenue $81.5M MT
National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024 CI
National Health Provides information to the Shareholders CI
National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2024 CI
Tranche Update on National Health Investors, Inc.'s Equity Buyback Plan announced on February 20, 2024. CI
National Health Investors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting CI
Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating MT
North American Morning Briefing : Stock Futures -2- DJ
BMO Capital Upgrades National Health Investors to Outperform From Market Perform MT
National Health Investors Insider Bought Shares Worth $586,882, According to a Recent SEC Filing MT
More news
1 day+1.11%
1 week-1.82%
Current month-1.10%
1 month+0.08%
3 months+9.72%
6 months+18.80%
Current year+17.01%
More quotes
1 week
64.00
Extreme 64.0001
66.72
1 month
63.91
Extreme 63.91
68.14
Current year
51.59
Extreme 51.59
68.14
1 year
48.51
Extreme 48.51
68.14
3 years
47.54
Extreme 47.54
69.23
5 years
31.37
Extreme 31.37
91.12
10 years
31.37
Extreme 31.37
91.12
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 15-01-25
Founder 78 90-12-31
Director of Finance/CFO 64 16-03-07
Members of the board TitleAgeSince
Director/Board Member 77 20-05-05
Founder 78 90-12-31
Director/Board Member 79 90-12-31
More insiders
Date Price Change Volume
24-06-12 65.35 +1.11% 153,853
24-06-11 64.63 +0.15% 134,784
24-06-10 64.53 -1.62% 109,727
24-06-07 65.59 -1.90% 128,680
24-06-06 66.86 +0.45% 85,521

Delayed Quote Nyse, June 12, 2024 at 04:00 pm

More quotes
National Health Investors, Inc. is a real estate investment trust. The Company specializes in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and lease, mortgage, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has 163 healthcare real estate properties located in 31 states and leased primarily pursuant to triple-net leases to 25 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The SHOP segment has 15 properties located in eight states with a combined 1,733 units.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
65.35 USD
Average target price
66.5 USD
Spread / Average Target
+1.76%
Consensus